Skip to main content
OpenTrials

Clinical trial condition

Endocrine System Diseases

Explore clinical trials studying Endocrine System Diseases. Study availability and eligibility vary by location and protocol.

91 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Endocrine System Diseases trial results

Active, not recruiting

Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer

NCT04807166

Conditions
Adnexal Diseases, Angiogenesis, Anlotinib, +22 more
Locations
  • Huai'an First People's Hospital Huai'an, China
  • Nanjing Drum Tower Hospital Nanjing, China
  • Zhongda Hospital Southeast University Nanjing, China
  • The First Affiliated Hospital of Soochow University Suzhou, China
View Trial Details
Completed

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

NCT05276063

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +20 more
Locations
  • Thrive Health Research Beverly Hills, California, United States
  • UC San Diego Health La Jolla, California, United States
  • UCLA Los Angeles, California, United States
  • Byers Eye Institute - Stanford University Palo Alto, California, United States
View all 30 locations
View Trial Details
Completed

A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency

NCT05171855

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +12 more
Locations
  • Ascendis Pharma Investigational Site Phoenix, Arizona, United States
  • Ascendis Pharma Investigational Site Torrance, California, United States
  • Ascendis Pharma Investigational Site Chicago, Illinois, United States
  • Ascendis Pharma Investigational Site Indianapolis, Indiana, United States
View all 85 locations
View Trial Details
Completed

A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism

NCT04701203

Conditions
Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations
  • Ascendis Pharma Investigational Site San Francisco, California, United States
  • Ascendis Pharma Investigational Site Chicago, Illinois, United States
  • Ascendis Pharma Investigational Site Rochester, Minnesota, United States
  • Ascendis Pharma Investigational Site Reno, Nevada, United States
View all 21 locations
View Trial Details
Completed

A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

NCT02781727

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +16 more
Locations
  • Ascendis Pharma Investigational Site Birmingham, Alabama, United States
  • Ascendis Pharma Investigational Site Little Rock, Arkansas, United States
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
  • Ascendis Pharma Investigational Site Orange, California, United States
View all 53 locations
View Trial Details
Completed

A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency

NCT03305016

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +15 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Neufeld Medical Group Inc. Los Angeles, California, United States
  • Center of Excellence in Diabetes and Endocrinology Sacramento, California, United States
  • Rocky Mountain Pediatric Endocrinology Centennial, Colorado, United States
View all 24 locations
View Trial Details
Completed

A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency

NCT04615273

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +15 more
Locations
  • Ascendis Pharma Investigational Site Birmingham, Alabama, United States
  • Ascendis Pharma Investigational Site Phoenix, Arizona, United States
  • Ascendis Pharma Investigational Site Fresno, California, United States
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
View all 113 locations
View Trial Details

Related conditions